Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | 93,631 | net | 19 Sept 2025 | tx 3+100,000−6,369 |
| PHAXIAM THERAPEUTICS | 44,104 | net | 08 Oct 2024 | tx 2+44,104 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Sept 2025 | EXERCISE | OSE IMMUNOTHERAPEUTICS | 90,000 | 0.40 EUR | |
| 08 Oct 2024 | PURCHASE | PHAXIAM THERAPEUTICS | 22,052 | 1.00 EUR | |
| 17 Jun 2024 | CONVERSION | OSE IMMUNOTHERAPEUTICS | 10,000 | 3.58 EUR | |
| 13 Jun 2024 | SALE | OSE IMMUNOTHERAPEUTICS | 6,369 | 7.20 EUR |